Correlation Between Inflection Point and Medicus Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inflection Point and Medicus Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inflection Point and Medicus Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inflection Point Acquisition and Medicus Pharma Ltd, you can compare the effects of market volatilities on Inflection Point and Medicus Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inflection Point with a short position of Medicus Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inflection Point and Medicus Pharma.

Diversification Opportunities for Inflection Point and Medicus Pharma

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Inflection and Medicus is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Inflection Point Acquisition and Medicus Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicus Pharma and Inflection Point is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inflection Point Acquisition are associated (or correlated) with Medicus Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicus Pharma has no effect on the direction of Inflection Point i.e., Inflection Point and Medicus Pharma go up and down completely randomly.

Pair Corralation between Inflection Point and Medicus Pharma

Assuming the 90 days horizon Inflection Point Acquisition is expected to under-perform the Medicus Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Inflection Point Acquisition is 1.87 times less risky than Medicus Pharma. The stock trades about -0.07 of its potential returns per unit of risk. The Medicus Pharma Ltd is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  277.00  in Medicus Pharma Ltd on December 22, 2024 and sell it today you would earn a total of  55.00  from holding Medicus Pharma Ltd or generate 19.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.16%
ValuesDaily Returns

Inflection Point Acquisition  vs.  Medicus Pharma Ltd

 Performance 
       Timeline  
Inflection Point Acq 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inflection Point Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Medicus Pharma 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Medicus Pharma Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Medicus Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Inflection Point and Medicus Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inflection Point and Medicus Pharma

The main advantage of trading using opposite Inflection Point and Medicus Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inflection Point position performs unexpectedly, Medicus Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicus Pharma will offset losses from the drop in Medicus Pharma's long position.
The idea behind Inflection Point Acquisition and Medicus Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk